New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Bayer's venture will undoubtedly be playing catch-up, but it is likely to be a few years before the first CRISPR-Cas9 molecule for human therapy enters clinical trials. Among the most hotly-tipped ...

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

the CRISPR complex is encapsulated in tiny oil droplets which are complexed with a customizable molecule that offers high degree of tissue specificity. Hence, directing the CRISPR-complex to ...

Report with the AI impact on market trends - The global genomics market size is estimated to grow by USD 5.21 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR ...

A team from UNIGE, the Max Planck Institute for Molecular Physiology in Dortmund, and Heinrich Heine University in Düsseldorf ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking innovations like mRNA cancer vaccines and CRISPR-based therapies.

The second generation came along about a dozen years ago, with the discovery of CRISPR, which stands for ... help protect themselves and a powerful molecule and tool that allows genes to be ...